These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1717543)

  • 1. Is autoimmune chronic active hepatitis a HCV-related disease?
    Magrin S; Craxì A; Fiorentino G; Fabiano C; Provenzano G; Pinzello GB; Palazzo U; Almasio P; Pagliaro L
    J Hepatol; 1991 Jul; 13(1):56-60. PubMed ID: 1717543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis.
    Nishiguchi S; Kuroki T; Ueda T; Fukuda K; Takeda T; Nakajima S; Shiomi S; Kobayashi K; Otani S; Hayashi N
    Ann Intern Med; 1992 Jan; 116(1):21-5. PubMed ID: 1309200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III.
    Mitchel LS; Jeffers LJ; Reddy KR; Cheinquer H; Coelho-Little E; Moreda R; Parker T; Silva M; Li XM; de Medina M
    Am J Gastroenterol; 1993 Jul; 88(7):1027-34. PubMed ID: 7686329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: a follow-up study.
    Goeser T; Müller HM; Solbach C; Gmelin K; Kurzen F; Kommerell B; Theilmann L
    Presse Med; 1994 Apr 30-May 7; 23(17):793-6. PubMed ID: 8078836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
    Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
    Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV-marker-positive autoimmune-type chronic active hepatitis: a possible relation between HCV infection and liver autoreaction.
    Zeniya M; Aizawa Y; Watanabe F; Kawabe T; Hara M; Sakaguchi M; Toda G
    Liver; 1994 Aug; 14(4):206-12. PubMed ID: 7526109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV.
    Lin HH; Hsu HY; Chang MH; Wang JT; Chen PJ; Chen DS
    J Formos Med Assoc; 1992 Jul; 91(7):729-30. PubMed ID: 1360305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection in chronic liver disease in Somalia.
    Aceti A; Taliani G; Bruni R; Sharif OS; Moallin KA; Celestino D; Quaranta G; Sebastiani A
    Am J Trop Med Hyg; 1993 Apr; 48(4):581-4. PubMed ID: 7683179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus replication in 'autoimmune' chronic hepatitis.
    Magrin S; Craxi A; Fabiano C; Fiorentino G; Almasio P; Palazzo U; Pinzello G; Provenzano G; Pagliaro L; Choo QL
    J Hepatol; 1991 Nov; 13(3):364-7. PubMed ID: 1725529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to hepatitis C virus and liver disease in volunteer blood donors.
    Alberti A; Chemello L; Cavalletto D; Tagger A; Dal Canton A; Bizzaro N; Tagariello G; Ruol A
    Ann Intern Med; 1991 Jun; 114(12):1010-2. PubMed ID: 1851402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-GOR and hepatitis C virus in autoimmune liver diseases.
    Michel G; Ritter A; Gerken G; Meyer zum Büschenfelde KH; Decker R; Manns MP
    Lancet; 1992 Feb; 339(8788):267-9. PubMed ID: 1346282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis.
    Czaja AJ; Taswell HF; Rakela J; Schimek CM
    Mayo Clin Proc; 1991 Jun; 66(6):572-82. PubMed ID: 1646353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of hepatitis C virus antibodies (tests ELISA 2 and RIBA 2) in a population of pregnant women in France].
    Roudot-Thoraval F; Deforges L; Girollet PP; Maria B; Milliez J; Pathier D; Duval J; Dhumeaux D
    Gastroenterol Clin Biol; 1992; 16(3):255-9. PubMed ID: 1582542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Taswell HF; Rakela J; Schimek CM
    Mayo Clin Proc; 1990 Oct; 65(10):1303-13. PubMed ID: 2170781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis.
    Fried MW; Draguesku JO; Shindo M; Simpson LH; Banks SM; Hoofnagle JH; Di Bisceglie AM
    Dig Dis Sci; 1993 Apr; 38(4):631-6. PubMed ID: 8384981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive markers for hepatitis C antibody ELISA specificity in Australian blood donors.
    Hyland CA; Kearns S; Young IF; Battistutta D; Morgan CL
    Transfus Med; 1992 Sep; 2(3):207-13. PubMed ID: 1285010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.
    Makuria AT; Raghuraman S; Burbelo PD; Cantilena CC; Allison RD; Gibble J; Rehermann B; Alter HJ
    Transfusion; 2012 Sep; 52(9):1940-8. PubMed ID: 22304422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of hepatitis C virus in the genesis of hepatic lesions observed in alcoholic patients with liver cirrhosis].
    Deny P; Halimi C; Trinchet JC; Munz C; Bianchi A; Mal F; Beaugrand M
    Gastroenterol Clin Biol; 1994; 18(2):110-4. PubMed ID: 7516902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of immunoassays for anti-HCV antibodies (ELISA and RIBA II) in patients with essential mixed cryoglobulinemia (EMC).
    Monteverde A; Airoldi G; Ballarè M; Fortina G; Quaglia V; Pigatto A; Manzini P
    Clin Exp Rheumatol; 1993; 11(6):609-13. PubMed ID: 7507807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.